REVIVEBIO was founded in April 2023 with the core mission of “harnessing microbial science to precisely regulate the immune system, address health challenges, enhance quality of life, and promote public well-being.” We are dedicated to applying cutting-edge microbiome research to the health and beauty industry.
Believing that microorganisms play a critical role in human health, REVIVEBIO focuses on the research and application of Next-Generation Probiotics (NGPs) and their postbiotics, delivering science-based solutions in key areas such as immune modulation, gut health, metabolic balance, and healthy aging.
To realize this vision, REVIVEBIO continues to strengthen its R&D capabilities and integrate academic, medical and industrial resources. From strain development and functional validation to formulation design and preclinical/clinical studies, we maintain a rigorous scientific approach in driving product innovations. At the same time, we are actively expanding into global markets, forging international collaborations and distribution networks, with the ambition of becoming a world-leading biotechnology player built on scientific excellence and trusted credibility.